Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.
about
Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@en
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@nl
type
label
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@en
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@nl
prefLabel
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@en
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@nl
P2093
P2860
P1476
Phase II study of palonosetron ...... e-day emetogenic chemotherapy.
@en
P2093
Hideaki Miyake
Junya Furukawa
Manabu Kume
Masato Fujisawa
Midori Hirai
Naomi Mizuta
Sachi Hirata
Takeshi Ioroi
Yuko Utsubo
P2860
P2888
P356
10.1007/S00520-017-3967-2
P577
2017-11-16T00:00:00Z